EAHAD 2025: Elevating Levels of Endogenous Circulating von Willebrand Factor (VWF): The Potential of HMB-002 as a Prophylactic Treatment of Von Willebrand Disease (VWD)
Presented at 18th Annual Congress of the European Association of Haemophilia and Allied Disorders
To view the presentation, click here